[1]
Friederich JA,Butterworth JF 4th, Sodium nitroprusside: twenty years and counting. Anesthesia and analgesia. 1995 Jul; [PubMed PMID: 7598246]
[2]
Hottinger DG,Beebe DS,Kozhimannil T,Prielipp RC,Belani KG, Sodium nitroprusside in 2014: A clinical concepts review. Journal of anaesthesiology, clinical pharmacology. 2014 Oct [PubMed PMID: 25425768]
[3]
Yancy CW,Jessup M,Bozkurt B,Butler J,Casey DE Jr,Drazner MH,Fonarow GC,Geraci SA,Horwich T,Januzzi JL,Johnson MR,Kasper EK,Levy WC,Masoudi FA,McBride PE,McMurray JJ,Mitchell JE,Peterson PN,Riegel B,Sam F,Stevenson LW,Tang WH,Tsai EJ,Wilkoff BL, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; [PubMed PMID: 23741058]
[4]
Whelton PK,Carey RM,Aronow WS,Casey DE Jr,Collins KJ,Dennison Himmelfarb C,DePalma SM,Gidding S,Jamerson KA,Jones DW,MacLaughlin EJ,Muntner P,Ovbiagele B,Smith SC Jr,Spencer CC,Stafford RS,Taler SJ,Thomas RJ,Williams KA Sr,Williamson JD,Wright JT Jr, 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex. : 1979). 2018 Jun; [PubMed PMID: 29133356]
[6]
Nishimura RA,Otto CM,Bonow RO,Carabello BA,Erwin JP 3rd,Guyton RA,O'Gara PT,Ruiz CE,Skubas NJ,Sorajja P,Sundt TM 3rd,Thomas JD, 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 10; [PubMed PMID: 24589852]
[7]
Erstad BL,Barletta JF, Treatment of hypertension in the perioperative patient. The Annals of pharmacotherapy. 2000 Jan; [PubMed PMID: 10669188]
[8]
Jauch EC,Saver JL,Adams HP Jr,Bruno A,Connors JJ,Demaerschalk BM,Khatri P,McMullan PW Jr,Qureshi AI,Rosenfield K,Scott PA,Summers DR,Wang DZ,Wintermark M,Yonas H, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar; [PubMed PMID: 23370205]
[9]
Ikram H,Low CJ,Crozier IG,Shirlaw T, Hemodynamic effects of nitroprusside on valvular aortic stenosis. The American journal of cardiology. 1992 Feb 1 [PubMed PMID: 1734649]
[10]
Pasceri V,Pristipino C,Pelliccia F,Granatelli A,Speciale G,Roncella A,Pironi B,Capasso M,Richichi G, Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. The American journal of cardiology. 2005 Jun 1 [PubMed PMID: 15904643]
[11]
Hallak JE,Maia-de-Oliveira JP,Abrao J,Evora PR,Zuardi AW,Crippa JA,Belmonte-de-Abreu P,Baker GB,Dursun SM, Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA psychiatry. 2013 Jul [PubMed PMID: 23699763]
[12]
Fok H,Jiang B,Clapp B,Chowienczyk P, Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels. Hypertension (Dallas, Tex. : 1979). 2012 Nov [PubMed PMID: 23045465]
[13]
Ivankovich AD,Miletich DJ,Tinker JH, Sodium nitroprusside: metabolism and general considerations. International anesthesiology clinics. 1978 Summer [PubMed PMID: 357297]
[14]
Palmer RF,Lasseter KC, Drug therapy. Sodium nitroprusside. The New England journal of medicine. 1975 Feb 6; [PubMed PMID: 1089194]
[15]
Tinker JH,Michenfelder JD, Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology. 1976 Sep [PubMed PMID: 962181]
[16]
Johanning RJ,Zaske DE,Tschida SJ,Johnson SV,Hoey LL,Vance-Bryan K, A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoning. Pharmacotherapy. 1995 Nov-Dec; [PubMed PMID: 8602386]
[17]
Schulz LT,Elder EJ Jr,Jones KJ,Vijayan A,Johnson BD,Medow JE,Vermeulen L, Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture. Hospital pharmacy. 2010 Oct 1; [PubMed PMID: 21625332]
[18]
Rindone JP,Sloane EP, Cyanide toxicity from sodium nitroprusside: risks and management. The Annals of pharmacotherapy. 1992 Apr; [PubMed PMID: 1533553]
[19]
Morris AA,Page RL 2nd,Baumgartner LJ,Mueller SW,MacLaren R,Fish DN,Kiser TH, Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions. Journal of intensive care medicine. 2017 Oct; [PubMed PMID: 27435907]
[20]
Vesey CJ,Cole PV, Blood cyanide and thiocyanate concentrations produced by long-term therapy with sodium nitroprusside. British journal of anaesthesia. 1985 Feb; [PubMed PMID: 3970795]